evidence table
Resveratrol Cognition Randomized Trial Evidence Table
Structured evidence table for Resveratrol Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Cognition Randomized Trial | Observational associations between dietary patterns and reduced dementia risk have prompted investigations of dietary bioactives (DBs) as cognitive nutraceuticals. | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Randomized Trial | Findings are synthesized qualitatively; no formal meta-analysis or risk of bias assessment was conducted. | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Randomized Trial | Cannabinoids improved behavioral symptoms but showed no measurable cognitive effects. | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Randomized Trial | Methods: This critical narrative review examines interventional trials for nine prominent DBs relevant to AD: docosahexaenoic acid (DHA), curcumin, resveratrol, epigallocatechin gallate (EGCG), nicotinamide riboside (NR), tricaprilin, vitamin E (α-tocopherol), cannabinoids, and NIC5-15 (D-pinitol). | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Randomized Trial | Dietary patterns have emerged as modifiable risk factors that may influence disease onset and progression. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
| Resveratrol Cognition Randomized Trial | The Mediterranean diet (MedDiet), rich in fruits, vegetables, whole grains, legumes, fish, and extra virgin olive oil, has been consistently associated with better cognitive outcomes and reduced risk of neurodegeneration. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
| Resveratrol Cognition Randomized Trial | Aim: This narrative review summarizes current evidence on the role of the MedDiet in slowing the progression of neurodegenerative diseases, with a particular focus on polyphenols such as resveratrol and oleuropein as key bioactive mediators. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
| Resveratrol Cognition Randomized Trial | Background: Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are among the leading causes of disability and mortality worldwide. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
Source documents